Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line
about
Comparison of human immunodeficiency virus (HIV)-specific infection-enhancing and -inhibiting antibodies in AIDS patients.Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infectionAn Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing AntibodiesInfection-Enhancing and -Neutralizing Activities of Mouse Monoclonal Antibodies against Dengue Type 2 and 4 Viruses Are Controlled by Complement LevelsIncreased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus infectionComplement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashionEnhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).Complement Protein C1q Interacts with DC-SIGN via Its Globular Domain and Thus May Interfere with HIV-1 Transmission.
P2860
Q24538755-2A974960-A1FA-43C3-A98E-02533D66601BQ24675546-FCC23949-7AC1-49CA-BF30-70B388BBAD9AQ27469507-EAD2FEBB-3906-485C-8BC3-C1F1C016020EQ27469837-E0445B55-1548-4088-B092-3E69F94ADADEQ27485321-07394075-CA6A-417A-BF0E-113AE3D5F11FQ35837798-2283202F-9D81-439F-B859-C138ABE107BCQ36230054-0F7C2569-D663-49A0-AA1F-D874BB8CBD37Q36230737-12708A0B-05AF-45F6-A607-82FC793FB3A8Q36645449-6BE85C91-C355-4A88-BCD3-2397E22F3DFCQ37525426-54726DB2-E6B8-42E5-9689-EDBA88A63AA0
P2860
Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell line
description
1991 nî lūn-bûn
@nan
1991 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Antibody-dependent and antibod ...... formed B-lymphocytic cell line
@ast
Antibody-dependent and antibod ...... formed B-lymphocytic cell line
@en
Antibody-dependent and antibod ...... formed B-lymphocytic cell line
@nl
type
label
Antibody-dependent and antibod ...... formed B-lymphocytic cell line
@ast
Antibody-dependent and antibod ...... formed B-lymphocytic cell line
@en
Antibody-dependent and antibod ...... formed B-lymphocytic cell line
@nl
prefLabel
Antibody-dependent and antibod ...... formed B-lymphocytic cell line
@ast
Antibody-dependent and antibod ...... formed B-lymphocytic cell line
@en
Antibody-dependent and antibod ...... formed B-lymphocytic cell line
@nl
P2860
P921
P1433
P1476
Antibody-dependent and antibod ...... formed B-lymphocytic cell line
@en
P2093
P2860
P407
P577
1991-01-01T00:00:00Z